30,000
Participants
Start Date
March 14, 2022
Primary Completion Date
January 31, 2025
Study Completion Date
October 31, 2025
Clinical data collection
Laboratory tests, Vital assessments, Maternal and fetal genotype testing, Antibodies Testing will be performed.
Icahn School of Medicine at Mount Sinai, New York
Columbia University Irving Medical Center, New York
New York-Presbyterian-Queens, New York
Weill Cornell Medicine-New York Presbyterian Hospital, New York
Temple Perinatal Diagnosis Center, Philadelphia
University of North Carolina at Chapel Hill, Chapel Hill
University of Miami Miller School of Medicine, Miami
Ohio State University Wexner Medical Center, Columbus
Wright State Physicians Obstetrics & Gynecology, Dayton
Javara Inc. - Forest, Dallas
The University of Texas Health Science Center at Houston, Houston
Javara Research Inc. - Dallas - PPDS, Houston
New Horizons Clinical Trials, LLC, Chandler
Zillan Clinical Research - Gardena, Gardena
Yale University School of Medicine, New Haven
Cooper University Hospital, Camden
Robert Wood Johnson Medical School, New Brunswick
St. Peter's University Hospital, New Brunswick
Rutgers New Jersey Medical School, Newark
Sunnybrook Health Sciences Centre, Toronto
Klinikum der Friedrich Schiller Universität Jena, Jena
Leids Universitair Medisch Centrum, Leiden
Oslo Universitetssykehus HF, Ullevål, Oslo
Universitetssykehuset Nord Norge, Tromsø
Barnmorskestationen Rosengård, Lund
Södersjukhuset, Stockholm
Clinical Trial Consultants - Uppsala, Uppsala
St. Thomas' Hospital, London
Lead Sponsor
Rallybio
INDUSTRY